Monday, August 13, 2018

XBIO To Report Phase 2 Data This Year, VNRX Abuzz, ATRS To Face FDA In Sep

The following are some of today's top gainers in the pharma/biotech sector.

from RTT - Biotech https://ift.tt/2Baxtna
via IFTTT
Posted by at
Labels: ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)